PMC:7534795 / 48093-48344 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T362","span":{"begin":143,"end":151},"obj":"Disease"}],"attributes":[{"id":"A362","pred":"mondo_id","subj":"T362","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"The antiviral agents lopinavir and ritonavir have been tested in a randomized controlled, open-label trial in hospitalized adult patients with COVID-19 and concluded that no benefit was observed with lopinavir–ritonavir treatment beyond standard care."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T293","span":{"begin":55,"end":61},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T294","span":{"begin":65,"end":66},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T295","span":{"begin":95,"end":100},"obj":"http://purl.obolibrary.org/obo/CLO_0007225"}],"text":"The antiviral agents lopinavir and ritonavir have been tested in a randomized controlled, open-label trial in hospitalized adult patients with COVID-19 and concluded that no benefit was observed with lopinavir–ritonavir treatment beyond standard care."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T73219","span":{"begin":4,"end":20},"obj":"Chemical"},{"id":"T21496","span":{"begin":21,"end":44},"obj":"Chemical"},{"id":"T50172","span":{"begin":21,"end":30},"obj":"Chemical"},{"id":"T14","span":{"begin":35,"end":44},"obj":"Chemical"},{"id":"T33412","span":{"begin":95,"end":100},"obj":"Chemical"},{"id":"T81685","span":{"begin":200,"end":209},"obj":"Chemical"},{"id":"T64788","span":{"begin":210,"end":219},"obj":"Chemical"}],"attributes":[{"id":"A74518","pred":"chebi_id","subj":"T73219","obj":"http://purl.obolibrary.org/obo/CHEBI_22587"},{"id":"A65726","pred":"chebi_id","subj":"T21496","obj":"http://purl.obolibrary.org/obo/CHEBI_145924"},{"id":"A62958","pred":"chebi_id","subj":"T50172","obj":"http://purl.obolibrary.org/obo/CHEBI_31781"},{"id":"A15931","pred":"chebi_id","subj":"T14","obj":"http://purl.obolibrary.org/obo/CHEBI_45409"},{"id":"A51979","pred":"chebi_id","subj":"T33412","obj":"http://purl.obolibrary.org/obo/CHEBI_35209"},{"id":"A54838","pred":"chebi_id","subj":"T81685","obj":"http://purl.obolibrary.org/obo/CHEBI_31781"},{"id":"A38640","pred":"chebi_id","subj":"T64788","obj":"http://purl.obolibrary.org/obo/CHEBI_45409"}],"text":"The antiviral agents lopinavir and ritonavir have been tested in a randomized controlled, open-label trial in hospitalized adult patients with COVID-19 and concluded that no benefit was observed with lopinavir–ritonavir treatment beyond standard care."}

{"project":"LitCovid-sentences","denotations":[{"id":"T408","span":{"begin":0,"end":251},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The antiviral agents lopinavir and ritonavir have been tested in a randomized controlled, open-label trial in hospitalized adult patients with COVID-19 and concluded that no benefit was observed with lopinavir–ritonavir treatment beyond standard care."}

{"project":"LitCovid-PubTator","denotations":[{"id":"1475","span":{"begin":129,"end":137},"obj":"Species"},{"id":"1479","span":{"begin":21,"end":30},"obj":"Chemical"},{"id":"1480","span":{"begin":35,"end":44},"obj":"Chemical"},{"id":"1481","span":{"begin":200,"end":219},"obj":"Chemical"},{"id":"1497","span":{"begin":143,"end":151},"obj":"Disease"}],"attributes":[{"id":"A1475","pred":"tao:has_database_id","subj":"1475","obj":"Tax:9606"},{"id":"A1479","pred":"tao:has_database_id","subj":"1479","obj":"MESH:D061466"},{"id":"A1480","pred":"tao:has_database_id","subj":"1480","obj":"MESH:D019438"},{"id":"A1481","pred":"tao:has_database_id","subj":"1481","obj":"MESH:C558899"},{"id":"A1497","pred":"tao:has_database_id","subj":"1497","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"The antiviral agents lopinavir and ritonavir have been tested in a randomized controlled, open-label trial in hospitalized adult patients with COVID-19 and concluded that no benefit was observed with lopinavir–ritonavir treatment beyond standard care."}